source
- Lycia Therapeutics files for IPO to fund antibody degrader platformLycia Therapeutics, a protein‑degradation startup built on research from Nobel laureate Carolyn Bertozzi, announced it has filed for an initial public offering. The filing is intended to raise cap…
- Abbott receives FDA clearance for CardioMEMS HF System updates enabling home pressure monitoring via smartphone appAbbott announced that the U.S. Food and Drug Administration has cleared updated software for its CardioMEMS HF System. The changes add a patient facing component through the CardioGuide HF mobile a…